The seventh hGH Symposium, Madrid, April 11-14, 1996
Author(s)
Bibliographic Information
The seventh hGH Symposium, Madrid, April 11-14, 1996
(Hormone research, v. 46,
Karger, 1996
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Presents the proceedings of the Seventh hGH Symposium, held in Madrid in 1996. Topics covered include: neuroendocrinology; GH, IGF-I and metabolism; and recent advances in hormone research.
Table of Contents
- Neuroendocrinology: Regulation of growth hormone secretion, M.F. Scalon et al
- Growth hormone-releasing peptides - clinical and basic aspects, J. Argente et al
- Interaction of the signalling pathways of insulin-like growth factor-I and sex steroids in the neuroendocrine hypothalamus, L.M. Garcia-Segura et al
- Diagnostic strategies in paediatric imaging, C. Adamsbaum, J.L. Chaussain
- Biochemical diagnostic strategies in the evaluation of short stature - the diagnosis of insulin-like growth factor deficiency, R.G. Rosenfeld
- Diagnosis of growth hormone deficiency in adults, M. Korbonits, M. Basser. GH, IGF-I and metabolism: Growth hormone, insulin-like growth factor-I and lipid metabolism - interactions with sex steroids, P. Bjorntorp
- Factors modifying growth hormone estimates in immunoassays, S. Fisher, H. Orskov
- Growth hormone in glucose counterregulation, P.E. Cryer
- The role of insulin-like growth factors and their binding proteins in tumour hypoglycaemia, R.C. Baxter The rationale for the use of recombinant human growth hormone and insulin-like growth factor-I for catabolic conditions in humans, M.W. Haymond, N. Mauras. Recent advances in therapy: Growth hormone treatment of idiopathic short stature, R.L. Hintz
- Use of human recombinant insulin-like growth factor-I in patients with human immunodeficiency virus infection, S. Hirschfield
- Recombinant human growth hormone in chronic and acute respiratory insufficiency, C. Pichard et al
- The German study group for growth hormone treatment in chronic renal failure - growth hormone as a new treatment modality for short children with chronic renal failure, O. Mehls et al. Special lecture: A history of growth hormone, R. Tattersall.
by "Nielsen BookData"